-

AIS Healthcare Recognizes March as Multiple Sclerosis Awareness Month

DALLAS--(BUSINESS WIRE)--AIS Healthcare is proud to recognize March as Multiple Sclerosis Awareness (MS) month. It is critical to raise awareness and amplify the stories of people living with MS. With nearly 1 million individuals living with MS in the United States, the fight for a cure has never been more important.

Nationally, there is a growing understanding of MS, a chronic disease of the central nervous system, affecting the brain, spinal cord, and optic nerves. “While treatments have been developed to treat the symptoms of MS including pain and spasticity, we must continue working towards a cure for every person living with this disease,” said Simon Castellanos, AIS Healthcare Chief Executive Officer. “AIS Healthcare is committed to providing people living with MS the medication and supports required to live meaningful and joyful lives.”

Though the cause of MS remains unknown, there are effective treatment options for patients that can help manage symptoms and provide support in leading a long and productive life. March is a time to raise awareness, educate society, fundraise, and support the scientific and health care community that is working towards a cure and deepening our understanding of MS.

About AIS Healthcare

Advancing quality. Improving lives.

As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.

Learn more at aiscaregroup.com.

Contacts

Simon Castellanos
877.443.4006

AIS Healthcare


Release Versions

Contacts

Simon Castellanos
877.443.4006

More News From AIS Healthcare

New Outpatient Infusion Center Opening in Marietta, GA Expands the National Presence of Advanced Infusion Care

DALLAS--(BUSINESS WIRE)--Advanced Infusion Care (AIC), a division of AIS Healthcare and a leading provider of personalized infusion therapy, is pleased to announce the opening of another Advanced Infusion Care Center (AICC). This latest one is in Marietta, GA represents a significant step forward in AIC’s ongoing expansion and its commitment to increasing access to compassionate, high-quality infusion services across the country. The opening of more and more AICC sites highlights AIC’s strategi...

Advanced Infusion Care (AIC) Now Offers Kedrion Biopharma’s YIMMUGO® (Immune Globulin Intravenous Human-Dira, 10% Liquid)

DALLAS--(BUSINESS WIRE)--AIC, a division of AIS Healthcare, now offers YIMMUGO®, manufactured by Kedrion Biopharma, for the treatment of primary humoral immunodeficiency in patients 2 years of age and older. Approved by the U.S. Food and Drug Administration in June 2024, YIMMUGO® is now available at all AIC locations. The nationally accredited infusion teams at AIC collaborate closely with physicians to provide specialized infusion services to patients in their home or in an infusion center set...

Advanced Infusion Care Expands National Footprint by Launching a New Outpatient Infusion Center in Phoenix, AZ

DALLAS--(BUSINESS WIRE)--Advanced Infusion Care (AIC), a division of AIS Healthcare and a leading provider of patient-specific infusion therapy, proudly announces the launch of Advanced Infusion Care Centers (AICC), with the opening of its first location in Phoenix, AZ. This new center marks a major milestone in AIC’s continued growth and its mission to expand access to compassionate, high quality infusion care nationwide. The creation of AICC reflects the company’s strategic commitment to meet...
Back to Newsroom